Your rationale in comparison of Sucanon and Metformin is reasonable given current limited information. I would also point out that in preclinical testing summarized at sucanonhealth.com, Sucanon outperformed biguanides (which include Metformin) and sulfonylureas (Micronase among others) in lab rat muscle, Sucanon also outperformed Glyburide in a 370 subject 6 month double blinded placebo controlled study. Presumably the results of the 12 week study conducted in Mexico City will be consistent with the above and other previous Sucanon studies.
I also agree that in the big picture the study results are very important especially when considering the previous study results for supporting information and perspective.
The only reason that I made any issue of the cash and financials is that I posted a brief accurate summary when financials were released and subsequently definitively refuted some inaccurate posted information and was told falsely that I "read the financial reports incorrectly". I'm all for vigorous debate on the issues, and welcome any who present facts to dispute anything that I post. I anticipate that may be difficult given that any of my stated facts are backed up by publicly available information.